These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 16823539)

  • 1. Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?
    Schöniger-Hekele M; Ramskogler K; Hartl D; Lesch OM; Müller C
    Wien Med Wochenschr; 2006 Apr; 156(7-8):216-22. PubMed ID: 16823539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of determining carbohydrate-deficient transferrin isoforms in the diagnosis of alcoholic liver disease.
    Stadheim LM; O'Brien JF; Lindor KD; Gores GJ; McGill DB
    Mayo Clin Proc; 2003 Jun; 78(6):703-7. PubMed ID: 12934779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there an analytical or diagnostic advantage from including trisialo transferrin into the fraction of carbohydrate-deficient transferrin? Lessons from a comparison of two commercial turbidimetric immunoassays with the carbohydrate-deficient transferrin determination by high-performance liquid chromatography.
    Lipkowski M; Dibbelt L; Seyfarth M
    Clin Biochem; 2000 Nov; 33(8):635-41. PubMed ID: 11166010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases.
    Bell H; Tallaksen C; Sjåheim T; Weberg R; Raknerud N; Orjasaeter H; Try K; Haug E
    Alcohol Clin Exp Res; 1993 Apr; 17(2):246-52. PubMed ID: 8488962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin isoform distribution: gender and alcohol consumption.
    Mårtensson O; Härlin A; Brandt R; Seppä K; Sillanaukee P
    Alcohol Clin Exp Res; 1997 Dec; 21(9):1710-5. PubMed ID: 9438535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carbohydrate-deficient transferrin. A new, highly specific marker for chronic alcohol consumption].
    Seitz G; Stickel F; Fiehn W; Werle E; Simanowski UA; Seitz HK
    Dtsch Med Wochenschr; 1995 Mar; 120(12):391-5. PubMed ID: 7705200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is carbohydrate-deficient transferrin a specific marker for alcohol abuse? A study in patients with chronic viral hepatitis.
    Perret R; Froehlich F; Lavanchy D; Henry H; Bachman C; Pécoud A; Bianchi L; Gonvers JJ
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1337-42. PubMed ID: 9347098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate-deficient transferrin as a marker of alcohol consumption in male patients with liver disease.
    Rublo M; Caballería J; Deulofeu R; Caballería L; Gassó M; Parés A; Vilella A; Giménez A; Ballesta A; Rodés J
    Alcohol Clin Exp Res; 1997 Aug; 21(5):923-7. PubMed ID: 9267545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of carbohydrate-deficient transferrin as a marker of alcohol abuse are significantly influenced by alterations in serum transferrin: comparison of two methods.
    Sorvajärvi K; Blake JE; Israel Y; Niemelä O
    Alcohol Clin Exp Res; 1996 May; 20(3):449-54. PubMed ID: 8727236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department.
    Bell H; Tallaksen CM; Try K; Haug E
    Alcohol Clin Exp Res; 1994 Oct; 18(5):1103-8. PubMed ID: 7847591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Latex CDT results in liver diseases.
    Chrostek L; Cylwik B; Gruszewska E; Panasiuk A; Szmitkowski M
    Alcohol Alcohol; 2012; 47(4):428-32. PubMed ID: 22582186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of carbohydrate-deficient transferrin for detection of alcohol abuse in patients with liver dysfunction.
    Stauber RE; Stepan V; Trauner M; Wilders-Truschnig M; Leb G; Krejs GJ
    Alcohol Alcohol; 1995 Mar; 30(2):171-6. PubMed ID: 7662035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further arguments against including trisialo-Fe2-transferrin in carbohydrate-deficient transferrin (CDT): a study on male alcoholics and hazardous drinkers.
    Arndt T; Korzec A; Bär M; Kropf J
    Med Sci Monit; 2002 Jun; 8(6):CR411-8. PubMed ID: 12070431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation by isoelectric focusing of the initial carbohydrate-deficient transferrin (CDT) and non-CDT transferrin isoform fractionation step involved in determination of CDT by the ChronAlcoI.D. assay.
    Hackler R; Arndt T; Helwig-Rolig A; Kropf J; Steinmetz A; Schaefer JR
    Clin Chem; 2000 Apr; 46(4):483-92. PubMed ID: 10759472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum carbohydrate-deficient transferrin in patients with nonalcoholic liver disease and with hepatocellular carcinoma.
    Murawaki Y; Sugisaki H; Yuasa I; Kawasaki H
    Clin Chim Acta; 1997 Mar; 259(1-2):97-108. PubMed ID: 9086297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of carbohydrate-deficient transferrin (CDT) in a general medical clinic: is this test useful in assessing alcohol consumption.
    Aithal GP; Thornes H; Dwarakanath AD; Tanner AR
    Alcohol Alcohol; 1998; 33(3):304-9. PubMed ID: 9632056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate-deficient transferrin as a marker of alcohol abuse: relationship to alcohol consumption, severity of liver disease, and fibrogenesis.
    Niemelä O; Sorvajärvi K; Blake JE; Israel Y
    Alcohol Clin Exp Res; 1995 Oct; 19(5):1203-8. PubMed ID: 8561291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum level of carbohydrate-deficient transferrin as a marker of alcoholic liver disease.
    Yamauchi M; Hirakawa J; Maezawa Y; Nishikawa F; Mizuhara Y; Ohata M; Nakajima H; Toda G
    Alcohol Alcohol Suppl; 1993; 1B():3-8. PubMed ID: 8003126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrin.
    Fagan KJ; Irvine KM; McWhinney BC; Fletcher LM; Horsfall LU; Johnson LA; Clouston AD; Jonsson JR; O'Rourke P; Martin J; Pretorius CJ; Ungerer JP; Powell EE
    Alcohol Clin Exp Res; 2013 Oct; 37(10):1771-8. PubMed ID: 23875541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.